Next Generation Sequencing Market Overview

The global next generation sequencing market size is estimated to grow from USD 10.2 billion to USD 45.08 billion by 2035, presenting a higher CAGR of 16% during the forecast period

Next generation sequencing (NGS) is an advanced technology used for sequencing of entire genome (including DNA and RNA) in order to understand the genetic variations related to diseases. This high-throughput sequencing method has been widely adopted in cancer studies, biomarkers discovery, molecular diagnostics, tailored therapies, and personalized medicine. The ability of NGS technology to sequence thousands of genetic sequences simultaneously has brought massive changes in research and diagnostics—researchers are able to determine the underlying causes of diseases at molecular level that help them to create personalized drugs to meet individual requirements. The primary objective of using the next generation sequencing method is to find similarities, mutations and variety inside the genome, making it a viable tool for analyzing rare genetic disorders, infectious diseases, and also for metagenomics studies.

Browse for more related promotions

· https://szotar.sztaki.hu/en/users/barbrasmith927